Matthew L. Bootsma

University of Wisconsin–Madison — United States

Medicine · Health Sciences

10h-index333citations70works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(44), Cancer Genomics and Diagnostics(19), Radiomics and Machine Learning in Medical Imaging(17), Cancer Cells and Metastasis(10), Molecular Biology Techniques and Applications(9)

Publications70 total

Abstract B023: Identifying therapeutic vulnerabilities in metastatic prostate cancer transcriptional phenotypes
Cancer Research·2026
Abstract B073: Circulating Tumor Cell (CTC) single cell protein quantification reveals inter-patient heterogeneity in PSMA expression associated with LuPSMA response in a Metastatic Castration Resistant Prostate Cancer (mCRPC) patient cohort
Cancer Research·2026
Supplementary Figure S1 from Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer
2025Open Access
Supplementary Tables S1-S4 from Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer
2025Open Access
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels
Nature Communications·2025· 2 citedOpen Access
Luminal Subtypes in Metastatic Prostate Cancer Circulating Tumor Cells Mirror Tissue and Are Associated with Prognosis and Response to 177Lu-PSMA-617
International Journal of Radiation Oncology*Biology*Physics·2025
Genetic and Epigenetic Reprogramming of Transposable Elements Drives ecDNA-Mediated Metastatic Prostate Cancer
2025· 1 citedOpen Access
Transcriptomic Signatures of Monocyte‐Derived Macrophages Associate With Androgen Receptor Pathway Inhibitor Progression in Prostate Cancer
The Prostate·2025· 1 citedOpen Access
Figure S10 from High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
2025Open Access
Figure 4 from High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
2025Open Access
Figure 6 from High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
2025Open Access
Data from High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
2025Open Access
Figure S11 from High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
2025Open Access
Table 1 from High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
2025Open Access
Table S2 from High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
2025Open Access
Figure 5 from High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
2025Open Access
Figure 3 from High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
2025Open Access
Figure 1 from High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
2025Open Access
Figure S9 from High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
2025Open Access
Figure S16 from High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
2025Open Access
page 1 of 4Next →

Frequent Co-authors

Shuang G. Zhao(40), Kyle T. Helzer(38), Joshua M. Lang(36), Marina N. Sharifi(31), Jamie M. Sperger(28), Amy K. Taylor(28), Grace C. Blitzer(28), David Kosoff(27), Martin Sjöström(26), John M. Floberg(23), Katherine R. Kaufmann(21), V. Carreño(21), Menggang Yu(20), Scott M. Dehm(20), Rana R. McKay(20), Felix Y. Feng(19), Shannon R. Reese(19), Luke A. Nunamaker(19), Charlotte Linebarger(19), Jennifer L. Schehr(18)